Skip to main content
. 2022 Jan 24;3(3):e193–e202. doi: 10.1016/S2666-5247(21)00280-9

Figure 2.

Figure 2

ARCoV antibody and neutralisation responses in phase 1

Geometric mean titres of the receptor binding domain-specific IgG by ELISA (A), neutralising antibodies to a pseudovirus (B), and live SARS-CoV-2 (C). Serum samples of the participants were collected at baseline (day 0), before the second dose (day 28), and after the second dose (days 35, 43, 56). Dots represent a serum sample. Bars represent geometric mean titre (SD). Numbers above dots show the geometric mean titre of the group. Dashed line indicates the lower limit of quantification.